Works matching AU Nakano, Takashi


Results: 467
    1
    2

    Concurrent chemoradiotherapy with conventional fractionated radiotherapy and low-dose daily cisplatin plus weekly docetaxel for T2N0 glottic cancer.

    Published in:
    2017
    By:
    • Jun-ichi Saitoh;
    • Katsuyuki Shirai;
    • Masumi Imaeda;
    • Atsushi Musha;
    • Takanori Abe;
    • Masato Shino;
    • Yukihiro Takayasu;
    • Katsumasa Takahashi;
    • Kazuaki Chikamatsu;
    • Takashi Nakano;
    • Saitoh, Jun-Ichi;
    • Shirai, Katsuyuki;
    • Imaeda, Masumi;
    • Musha, Atsushi;
    • Abe, Takanori;
    • Shino, Masato;
    • Takayasu, Yukihiro;
    • Takahashi, Katsumasa;
    • Chikamatsu, Kazuaki;
    • Nakano, Takashi
    Publication type:
    journal article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Nuclear survivin expression predicts poorer prognosis in glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2009, v. 91, n. 3, p. 353, doi. 10.1007/s11060-008-9720-4
    By:
    • Katsuyuki Shirai;
    • Yoshiyuki Suzuki;
    • Kuniyuki Oka;
    • Shin-ei Noda;
    • Hiroyuki Katoh;
    • Yoshihiko Suzuki;
    • Jun Itoh;
    • Hideaki Itoh;
    • Shogo Ishiuchi;
    • Hideyuki Sakurai;
    • Masatoshi Hasegawa;
    • Takashi Nakano
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan.

    Published in:
    International Journal of Hematology, 2023, v. 118, n. 4, p. 419, doi. 10.1007/s12185-023-03630-x
    By:
    • Nishimura, Jun-ichi;
    • Kawaguchi, Tatsuya;
    • Ito, Shuichi;
    • Murai, Hiroyuki;
    • Shimono, Akihiko;
    • Matsuda, Takahisa;
    • Fukamizu, Yuji;
    • Akiyama, Hirozumi;
    • Hayashi, Hideo;
    • Nakano, Takashi;
    • Maruyama, Shoichi
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    α‐Emitting cancer therapy using <sup>211</sup>At‐AAMT targeting LAT1.

    Published in:
    Cancer Science, 2021, v. 112, n. 3, p. 1132, doi. 10.1111/cas.14761
    By:
    • Kaneda‐Nakashima, Kazuko;
    • Zhang, ZiJian;
    • Manabe, Yoshiyuki;
    • Shimoyama, Atsushi;
    • Kabayama, Kazuya;
    • Watabe, Tadashi;
    • Kanai, Yoshikatsu;
    • Ooe, Kazuhiro;
    • Toyoshima, Atsushi;
    • Shirakami, Yoshifumi;
    • Yoshimura, Takashi;
    • Fukuda, Mitsuhiro;
    • Hatazawa, Jun;
    • Nakano, Takashi;
    • Fukase, Koichi;
    • Shinohara, Atsushi
    Publication type:
    Article
    49
    50